The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
US real-world first-line (1L) treatment patterns and outcomes for patients with metastatic urothelial carcinoma (mUC) following maintenance avelumab approval.
 
Haojie Li
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Lisa Herms
Employment - ConcertAI; McKesson
 
Traci Leong
Employment - McKesson
 
Paul R. Conkling
Research Funding - Aptose Biosciences; Arcus Biosciences; Bristol-Myers Squibb; Ignyta/Genentech/Roche; Janssen; US Oncology
 
Sonia Franco
No Relationships to Disclose
 
Puneet Singhal
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Ronac Mamtani
Honoraria - Flatiron Health
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Genentech/Roche; Seattle Genetics/Astellas
Research Funding - Merck
 
Manojkumar Bupathi
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Pfizer
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Exelixis
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Exelixis; Janssen Oncology; Pfizer